Addiction

Government of Canada announces appointments to the Canadian Institutes of Health Research Governing Council

Retrieved on: 
Wednesday, January 31, 2024
Knowledge, Partnership, Medicine, Mental health, University of Toronto, CIHR, Hospital, Institute of Medical Sciences, First Nations, Research, University, Evaluation, Sustainability, Social work, Personal ordinariate, Pharmacology, Faculty, Public health, Management, Addiction, Public, Mental, St. Michael's Hospital, Toxicology, Democracy, CAMH, Parliament, Organization

Dr. Bernard Le Foll is a senior scientist specializing in drug addiction within the Institute for Mental Health Policy Research at the Centre for Addiction and Mental Health (CAMH).

Key Points: 
  • Dr. Bernard Le Foll is a senior scientist specializing in drug addiction within the Institute for Mental Health Policy Research at the Centre for Addiction and Mental Health (CAMH).
  • He is also Vice-President Research and Academics and Chief Scientific Officer of the Waypoint Centre for Mental Health Care.
  • "I am very pleased to announce three appointments to the Canadian Institutes of Health Research (CIHR) Governing Council.
  • The Canadian Institutes of Health Research (CIHR) is part of the Health Portfolio, which supports the Minister of Health in maintaining and improving the health of Canadians.

Voices for Non-Opioid Choices Coalition Applauds Introduction of Legislation to Expand Access to Non-Opioid Pain Management Options for Seniors

Retrieved on: 
Tuesday, January 30, 2024
Congress, Alternatives, Medicare Part D, Opioid, Patient, Pain, FDA, Pharmacy, Addiction, Voices, Medicare

WASHINGTON, Jan. 30, 2024 /PRNewswire/ -- Today, Congress took a crucial step forward in the fight to prevent opioid addiction by introducing the bipartisan Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act. Championed by Representative Mariannette Miller-Meeks (R-IA) and Representative Tony Cárdenas (D-CA), the Alternatives to PAIN Act will prevent unnecessary exposure to opioids and open up access to innovative pain management therapies for American seniors.

Key Points: 
  • Championed by Representative Mariannette Miller-Meeks (R-IA) and Representative Tony Cárdenas (D-CA), the Alternatives to PAIN Act will prevent unnecessary exposure to opioids and open up access to innovative pain management therapies for American seniors.
  • "In order to save lives, the Alternatives to PAIN Act will ensure that seniors will have access to the full range of pain treatment modalities."
  • The NOPAIN Act expands patient and provider access to FDA-approved non-opioid pain management approaches in outpatient surgical settings beginning in 2025.
  • The Alternatives to PAIN Act builds on this by ensuring access to non-opioid approaches at the pharmacy counter.

Prime Minister announces changes to the parliamentary secretary team

Retrieved on: 
Tuesday, January 30, 2024
Government, Parliament, Mona Fortier, House, Mental health, Legislation, House of Commons, Commons, Addiction, Cabinet, Social change

OTTAWA, ON, Jan. 30, 2024 /CNW/ - The Prime Minister, Justin Trudeau, today announced the following changes to the parliamentary secretary team:

Key Points: 
  • OTTAWA, ON, Jan. 30, 2024 /CNW/ - The Prime Minister, Justin Trudeau, today announced the following changes to the parliamentary secretary team:
    Élisabeth Brière becomes Parliamentary Secretary to the Minister of Mental Health and Addictions and Associate Minister of Health, in addition to her role as Parliamentary Secretary to the Minister of Families, Children and Social Development
    In their new roles, Ms. Brière, Mr. Housefather, and Mr. Naqvi will support their respective cabinet ministers to make progress on the priorities that matter most to Canadians.
  • The Prime Minister also announced the appointment of Mona Fortier as Deputy Government Whip.
  • Parliamentary secretaries are chosen by the Prime Minister to assist ministers.
  • Parliamentary secretaries are not members of Cabinet and do not play a formal role in the Cabinet decision-making process.

Complete Ketamine Solutions Launches Breakthrough Addiction Recovery Program

Retrieved on: 
Tuesday, January 30, 2024
Hope, Ketamine, NAD, Addiction, DSM-IV codes, Mental health, Conceptual model, CKS, Pharmaceutical industry

STAMFORD, Conn., Jan. 30, 2024 /PRNewswire-PRWeb/ -- Complete Ketamine Solutions of Stamford (CKS), a pioneer in ketamine therapy, is proud to announce the launch of its groundbreaking Addiction Recovery Protocol, aimed at providing a comprehensive and effective solution for individuals battling addiction. This 6-week intensive program integrates cutting-edge ketamine infusions, NAD infusions, and specialized IV medications, combined with talk therapy, to address addiction challenges with a holistic approach.

Key Points: 
  • Transformative Addiction Treatment Integrates Ketamine and NAD Infusions at Stamford, CT Location
    STAMFORD, Conn., Jan. 30, 2024 /PRNewswire-PRWeb/ -- Complete Ketamine Solutions of Stamford (CKS), a pioneer in ketamine therapy , is proud to announce the launch of its groundbreaking Addiction Recovery Protocol , aimed at providing a comprehensive and effective solution for individuals battling addiction.
  • "We are witnessing profound transformations through our Addiction Recovery Protocol, reinforcing our belief in the power of ketamine therapy."
  • The Addiction Recovery Protocol consists of 8 two-hour ketamine infusions, 6 NAD infusions, and personalized IV medications administered during each session.
  • CKS recognizes the pressing need for innovative solutions in addiction recovery and aims to raise awareness about the efficacy of ketamine therapy in addressing not only mood disorders but also addiction.

Oregon Health Authority Buried Report Proving Higher Taxes Don’t Curb Excessive Alcohol Use

Retrieved on: 
Friday, January 26, 2024
Addiction, Beer, Bias, Mental health, Wine, Oregon Health Authority, Task force, News, Recycling

PORTLAND, Ore., Jan. 26, 2024 (GLOBE NEWSWIRE) -- The Oregonian reported breaking investigative news the Oregon Health Authority appears to have intentionally withheld a publicly funded report that contradicted its position on alcohol tax increases.

Key Points: 
  • PORTLAND, Ore., Jan. 26, 2024 (GLOBE NEWSWIRE) -- The Oregonian reported breaking investigative news the Oregon Health Authority appears to have intentionally withheld a publicly funded report that contradicted its position on alcohol tax increases.
  • The report by reputable Oregon economists and researchers from EcoNorthwest, which should have been published in 2021, found alcohol taxes “are far less likely to reduce consumption in heavy and excessive drinkers.” The Oregon Beverage Alliance issued the following statement:
    “This shocking news is deeply concerning that the Oregon Health Authority appears to have intentionally buried a taxpayer-funded study it commissioned because the findings contradicted efforts to justify raising alcohol taxes,” said the Oregon Beverage Alliance.
  • “As the Task Force on Alcohol Pricing and Addiction Services prepares to hear more potential bias and inaccuracies from Oregon Health Authority at the upcoming, Feb. 1, meeting, how can members trust the information Oregon Health Authority is providing to stakeholders and policymakers?
  • If Oregon Health Authority, and possibly others, knew about the report findings in 2021, and yet continued to advocate that increasing alcohol taxes would reduce consumption for problem drinkers, this appears deceptive and we demand answers.

Knock Out Opioid Abuse Day Learning Series Returns in 2024

Retrieved on: 
Wednesday, January 24, 2024
Drug, University, Addiction, Advertising, Partnership, Emergency medicine, Fentanyl, Emergency medical services, American Academy, Government, Communication, Public, Heroin, COVID-19, CME, New Jersey Medical School, Organization, Law enforcement, Prohibition

Millburn, NJ, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Partnership for a Drug-Free New Jersey (PDFNJ), the Office of the New Jersey Coordinator for Addiction Responses and Enforcement Strategies (NJ CARES) and the Opioid Education Foundation of America (OEFA) have renewed their partnership in 2024 and will once again host the Knock Out Opioid Abuse Day Learning Series.

Key Points: 
  • Millburn, NJ, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Partnership for a Drug-Free New Jersey (PDFNJ), the Office of the New Jersey Coordinator for Addiction Responses and Enforcement Strategies (NJ CARES) and the Opioid Education Foundation of America (OEFA) have renewed their partnership in 2024 and will once again host the Knock Out Opioid Abuse Day Learning Series.
  • Over the course of 11 webinars from January to December 2024, the series will offer the public more insight and information into the multi-faceted components of the opioid epidemic in New Jersey and around the nation.
  • The series is a branch of PDFNJ’s Knock Out Opioid Abuse Day statewide initiative, which has been held annually on October 6 since 2016 to educate residents and prescribers on the risks of prescription opioids and to raise awareness of the opioid crisis throughout the state.
  • To learn more about Knock Out Opioid Abuse Day and for a schedule of webinars, please visit knockoutday.drugfreenj.org .

Pelago Expands C-Suite with Top Industry Talent to Position Company for Next Phase of Growth

Retrieved on: 
Thursday, January 25, 2024
Telemedicine, Virtual Medicine, Data Management, Other Health, Technology, Audio, Video, Managed Care, Mental Health, General Health, Hospitals, Other Technology, Software, Networks, Internet, Health, Mobile, Wireless, Online, Senior, Psychiatry, Capella University, Addiction, Fertility, Associate, Ziff Davis, Psychotherapy, Opioid, Fintech, Suds, Partnership, Business administration, Oxford University Press, Global Payments, University, Mentorship, Behavior, Bonnier, Acquisition, UCLA, National Geographic, Product management, Master of Business Administration, TSYS, New Harbinger Publications, Cognitive behavioral therapy, Marketing, Dun & Bradstreet, Tobacco, Offers.com, Dun, Engineering, ROI, Management

Additionally, Ed Daley has been promoted to Chief Commercial Officer, and Paige Swanepoel has been promoted to Chief Marketing Officer.

Key Points: 
  • Additionally, Ed Daley has been promoted to Chief Commercial Officer, and Paige Swanepoel has been promoted to Chief Marketing Officer.
  • Dr. Glasner will oversee Pelago’s clinical research programs and ROI validation, and support product development from a clinical perspective.
  • His experience includes business planning, partnership development, and client growth and management as well as building and mentoring high performing teams.
  • Pelago is revolutionizing substance use management and leading the industry with its 3x ROI and 100% fees-at-risk business model, based on validated clinical outcomes and performance metrics.

Tris Pharma Appoints Franchesca Fowler to Chief Compliance Officer and Vice President, General Counsel

Retrieved on: 
Monday, January 22, 2024
Biotechnology, Neurology, Mental Health, Health, Pharmaceutical, Ketan, Patient, Pharma, JD, IP, Fordham University, Rutgers Law School, Culture, Addiction, Attention deficit hyperactivity disorder, Pain, DSM-IV codes, Bachelor of Science, Pharmaceutical industry

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the appointment of Franchesca Fowler, JD, as chief compliance officer and vice president, general counsel.

Key Points: 
  • Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the appointment of Franchesca Fowler, JD, as chief compliance officer and vice president, general counsel.
  • Ms. Fowler will oversee all legal matters within the company, including legal compliance, IP management, litigation and more.
  • Ms. Fowler received her Bachelor of Science in Finance from Fordham University and her Juris Doctor degree from Rutgers Law School.
  • “My decision to join Tris Pharma was driven not only by its exciting pipeline and growth prospects, but also the exceptional team of dedicated professionals.

The Honorable Patrick J. Kennedy Joins Healthsperien to Establish New Mental Health and Addiction Policy Practice

Retrieved on: 
Wednesday, January 24, 2024
DSM-IV codes, Hope, Commission, House, Addiction, Principal, Partner, Policy, Insurance, Louisiana House of Representatives, Mental health, Parity, Movement, Caregiver, Congress, Bell Trade Act, Opioid, Progress, Private sector, Act, Representative

WASHINGTON, Jan. 24, 2024 /PRNewswire/ -- Healthsperien, LLC, a leading national health care policy consulting firm, announced today that former US Representative Patrick J. Kennedy has been named as a Partner with the firm and will establish and lead a new national mental health and addiction policy practice. Rep. Kennedy will bring his decades of national leadership, advocacy, and expertise in mental health to advise a diverse array of clients, focusing on mental health and addiction, community-based services and supports, and the need for health system transformation.

Key Points: 
  • WASHINGTON, Jan. 24, 2024 /PRNewswire/ -- Healthsperien , LLC, a leading national health care policy consulting firm, announced today that former US Representative Patrick J. Kennedy has been named as a Partner with the firm and will establish and lead a new national mental health and addiction policy practice.
  • Rep. Kennedy will bring his decades of national leadership, advocacy, and expertise in mental health to advise a diverse array of clients, focusing on mental health and addiction, community-based services and supports, and the need for health system transformation.
  • Rep. Kennedy now brings his wealth of expertise to Healthsperien, where he will advance federal health policy to ensure quality care for those with mental health and addiction disorders.
  • "Representative Kennedy stands as a beacon of hope for transforming the national narrative on addiction and mental health.

SAFE Project Takes a Stand Launching New Country Song "It Ain't 5 O'clock Somewhere" to Commemorate Dry January and Share a Message of Moderation

Retrieved on: 
Monday, January 22, 2024
NBC, Hope, Alcoholism, Music, Addiction, Pandora, Drinking, Beer, Culture, Radio, Mental health, OHG, Shattered Dreams, IHeartRadio, YouTube Music, Splenic infarction, Liver disease

NEW YORK, Jan. 22, 2024 /PRNewswire/ -- Starting today and beyond Dry January, country music listeners will have a new song playing on radio stations promoting healthy, responsible drinking habits rather than the industry's often all too obsessed alcohol fixation. With 40% of popular country songs mentioning alcohol, which can encourage listeners to drink, SAFE Project set out to create a country music song encouraging people not to.

Key Points: 
  • With 40% of popular country songs mentioning alcohol, which can encourage listeners to drink, SAFE Project set out to create a country music song encouraging people not to.
  • The song challenges the glorification of drinking alcohol in country music, while the campaign urges responsible drinking all year long and prompts a critical look at the genre's prevailing culture.
  • There is no shame in asking for help or in talking about addiction," said Leslie Plaia, Executive Director, Substance Use and Behavioral Health at SAFE Project.
  • SAFE Project wants more people with addiction to take the No Shame Pledge and get help.